Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 66 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,336,056 | -82.5% | 358,945 | -76.5% | 0.01% | -81.7% |
| Q1 2024 | $24,830,646 | +5623.7% | 1,527,100 | +1818.5% | 0.06% | +5900.0% |
| Q3 2023 | $433,820 | -83.3% | 79,600 | -79.2% | 0.00% | -87.5% |
| Q2 2023 | $2,604,556 | +45.5% | 383,587 | +7.4% | 0.01% | +33.3% |
| Q1 2023 | $1,789,661 | -18.4% | 357,218 | -20.5% | 0.01% | -14.3% |
| Q4 2022 | $2,193,218 | +219.7% | 449,430 | +1398.1% | 0.01% | +75.0% |
| Q2 2019 | $686,000 | +415.8% | 30,000 | +500.0% | 0.00% | +300.0% |
| Q3 2018 | $133,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $84,238,000 | 6.25% |
| Burrage Capital Management LLC | 123,025 | $4,723,000 | 3.73% |
| MPM BioImpact LLC | 337,291 | $12,949,000 | 3.12% |
| First Light Asset Management, LLC | 608,193 | $23,349,000 | 2.39% |
| Cormorant Asset Management, LP | 1,397,700 | $53,658,000 | 2.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 396,521 | $15,222,000 | 1.50% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 801 | $33,000 | 0.61% |
| Artal Group S.A. | 285,028 | $10,942,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 298,213 | $11,448,000 | 0.24% |
| Virtus ETF Advisers LLC | 7,309 | $281,000 | 0.15% |